• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Ortinlab Share Price

    Ortin Laboratories Share PriceOrtin Laboratories

    Small Cap 3.2k Result
    ₹19.1
    -0.2 (-1.04%)
    As on 27 September, 2023 | 10:35 BSE: 539287 NSE: ORTINLABISIN: INE749B01020

    Ortin Laboratories Performance

    Day Range

    • Low 19.1
    • High 20
    19.1

    52 Week Range

    • Low 16.2
    • High 30.35
    19.1
    • Open Price20
    • Previous Close19.3
    • Volume564

    Start SIP in Ortin Laboratories

    Start SIP

    Ortin Laboratories Share Price

    • Over 1 Month -3.05%
    • Over 3 Month -17.32%
    • Over 6 Month -4.02%
    • Over 1 Year -17.67%

    Ortin Laboratories Key Statistics

    P/E Ratio 41.3
    PEG Ratio 0.3
    Market Cap Cr 16
    Price to Book Ratio 1.4
    EPS -0.1
    Dividend 0
    Relative Strength Index 40.71
    Money Flow Index 28.73
    MACD Signal -0.09
    Average True Range 0.74

    Ortin Laboratories Investment Rating

    • Master Rating:

    • Ortin Laboratories has an operating revenue of Rs. 4.97 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Ortin Laboratories Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 211132
    Operating Expenses Qtr Cr 121123
    Operating Profit Qtr Cr 001000
    Depreciation Qtr Cr 000000
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 000000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 68
    Operating Expenses Annual Cr 58
    Operating Profit Annual in Cr 10
    Depreciation Cr 00
    Interest Annual Cr 01
    Tax Annual Cr 00
    Net Profit Annual Cr 00
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2
    Cash from Investing Activity Annual Cr 0
    Cash from Financing Annual Activity Cr 0
    Net Cash Flow Annual Cr 2
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1111
    Fixed Assets Annual Cr 1415
    Total Non Current Assets Annual Cr 1515
    Total Current Assets Annual Cr 76
    Total Assets Annual Cr 2121
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 1313
    ROE Annual % -1-4
    ROCE Annual % 22
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 97
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Ortin Laboratories Technicals

    EMA & SMA

    Current Price
    ₹19.1
    -0.2 (-1.04%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹19.69
    • 50 Day
    • ₹19.99
    • 100 Day
    • ₹20.41
    • 200 Day
    • ₹21.23
    • 20 Day
    • ₹19.73
    • 50 Day
    • ₹19.85
    • 100 Day
    • ₹20.54
    • 200 Day
    • ₹21.32

    Ortin Laboratories Resistance and Support

    PIVOT
    ₹19.37
    Resistance
    First Resistance ₹19.59
    Second Resistance ₹19.87
    Third Resistance ₹20.09
    RSI 40.71
    MFI 28.73
    MACD Single Line -0.09
    MACD -0.1
    Support
    First Resistance ₹19.09
    Second Resistance ₹18.87
    Third Resistance ₹18.59

    Ortin Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 6,391 639,100 100
    Week 9,970 997,000 100
    1 Month 11,625 1,162,510 100
    6 Month 63,774 3,965,472 62.18

    Ortin Laboratories Result Highlights

    Ortin Laboratories Synopsis

    NSE-Medical-Diversified

    Ortin Laborator. belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 6.02 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2023. Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885.
    Market Cap 16
    Sales 5
    Shares in Float 0.76
    No of funds
    Yield
    Book Value 1.44
    U/D Vol ratio 0.6
    LTDebt / Equity 27
    Alpha -0.05
    Beta 0.22

    Ortin Laboratories

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 7.36%21.51%15.68%15.68%
    Foreign Portfolio Investors
    Individual Investors 86.93%73.83%79.59%77.73%
    Others 5.71%4.66%4.73%6.59%

    Ortin Laboratories Management

    Name Designation
    Mr. J R K Panduranga Rao Chairman & Managing Director
    Mr. S Murali Krishna Murthy Managing Director
    Mr. S Srinivas Kumar WholeTime Director & CFO
    Mr. G Venkata Ramana Non Executive Director
    Mr. Bh Satyanarayana Raju Non Executive Director
    Mr. S Balaji Venkateswarlu Non Executive Director
    Mr. B Gopal Reddy Independent Director
    Mr. Murali Krishna Rayaprolu Independent Director
    Ms. Pottur Sujatha Independent Director

    Ortin Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Ortin Laboratories Corporate Action

    Date Purpose Remarks
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results
    2022-11-14 Quarterly Results
    2022-08-13 Quarterly Results
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Ortin Laboratories FAQs

    What is Share Price of Ortin Laboratories ?

    Ortin Laboratories share price is ₹19 As on 27 September, 2023 | 10:21

    What is the Market Cap of Ortin Laboratories ?

    The Market Cap of Ortin Laboratories is ₹15.5 Cr As on 27 September, 2023 | 10:21

    What is the P/E ratio of Ortin Laboratories ?

    The P/E ratio of Ortin Laboratories is 41.3 As on 27 September, 2023 | 10:21

    What is the PB ratio of Ortin Laboratories ?

    The PB ratio of Ortin Laboratories is 1.4 As on 27 September, 2023 | 10:21

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.